Kestenberg-Messina Kaitlin M. bought ADMA
February 9, 2026 · Form 4 insider transaction
Kestenberg-Messina Kaitlin M. bought 144,230 shares of ADMA Biologics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
144,230
Price
$0.00
Total value
N/A
RoleOfficer
CompanyADMA Biologics, Inc. (ADMA)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 9, 2026
Filing dateFebruary 11, 2026
Shares owned after144,230
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options vest over four years with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on February 9, 2030 in accordance with the Plan.